bioRxiv · 10.1101/2025.09.18.677237
Nicotinamide opposes ET-1's adverse effect on uterine decidualization via EDNRB
Abstract
Endothelin-1 is involved in pathogenesis of preeclampsia. Mice (Edn1H/+) having excess endothelin-1 developed preeclampsia-like phenotypes during pregnancy in a maternal genotype-dependent manner. Here, we investigate whether decidualization is impaired in Edn1H/+ dams, and whether nicotinamide (a potent inhibitor of endothelin-1) exerts beneficial effect. We compared implantation sites between wild type (WT) and Edn1H/+ dams with or without nicotinamide treatment. Implantation sites of Edn1H/+ dams exhibited abnormal ectoplacental cone and sinusoids with reduced vascular density in mesometrial regions of deciduae. There was more VEGF in decidua of Edn1H/+ dams than WT dams. Markers of decidualization were decreased in Edn1H/+ dams. Nicotinamide supplementation corrected this abnormality. During differentiation (decidualization) of cultured human endometrial stomal cells, endothelin-1 impaired the upregulated expression of decidualization markers. The endothelin-1s effect was reversed by nicotinamide. These results show nicotinamide counteracts ET-1s detrimental effects on endometrial decidualization and has potential to improve embryo implantation and subsequent pregnancy outcomes.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Wang, Y., Ma, Q., Chen, M., Kayashima, Y., Zhou, J., Rao, B., Bowser, J. L., Yi, X., Maeda-Smithies, N., Li, F.. 2025-09-19. Nicotinamide opposes ET-1's adverse effect on uterine decidualization via EDNRB. https://doi.org/10.1101/2025.09.18.677237
Cite the original work for its findings. Save a collection to share your selection of sources.